Frequently Asked Questions
Trial participant Ailsa Guidi, Ailsa's husband Robert, and Dr Sean Apap Mangion
In this section we address some of the most frequently asked questions about taking part in the trial.
Please select one of the sections below to find a list of questions.
Recruitment and Registration of Interest FAQs
FAQs about recruitment and the Registration of Interest process
Trial Participation FAQs
Questions about practicalities of taking part in the trial.
Analysis Stage 2 FAQs
Questions about practicalities of taking part in Analysis Stage 2 of the trial.
The Octopus trial: Your questions answered
N.B. Whilst this video refers to the Octopus Trial, it is applicable to both UK and Australian participants who are recruited to the trial. Octopus is the name of the trial in the UK and the Australian extension is called Platypus.
Video chapters:
00:00 - Intro
01:17 - What will I need to do if I want to take part?
02:39 - How often will I need to visit the hospital or clinic?
03:47 - How long could the six-monthly visits go on for?
03:52 - How long does each visit take?
04:30 - Do I have to take part in Octopus?
04:54 - Can I stop taking part after I've joined the study already?
05:55 - Why is there a placebo or dummy drug?
06:41 - When will I find out what treatment I've been on?
07:25 - Could I experience some side effects?
09:01 - What if I'm taking other medications?
09:45 - Are there any other precautions I should take?
11:24 - When should I stop taking the trial medication?
12:23 - Will I get back any travel costs?
12:37 - Ending
Octopus is funded by the MS Society with supported funding from MS Australia and MSWA for the Australian extension Platypus
